Wednesday, March 05, 2008
Print This Page Intervet to Supply France With Minimum of 27 Million Doses of Bluetongue Vaccine
FRANCE - Intervet is working intensively to supply the Bovilis BTV 8 vaccine to France as soon as possible, to support the French government and farming sector in its fight against this devastating disease.
As the global leader in the development and supply of vaccines to support animal health and welfare, Intervet has been actively working on this virus since its emergence in Northern Europe in 2006 and developed a vaccine against Bluetongue serotype 8 in a very short time to meet the urgent need as quickly as possible. Intervet already received firm orders from the UK and the Netherlands. Intervet is currently optimizing the production process and is doing the utmost to speed up the first deliveries for mid-spring.
The vaccine has been developed for sheep and for cattle. While sheep need to be vaccinated once, cattle will need two vaccinations. The Bluetongue control strategy and vaccine purchase and supply are defined by the national authorities.
Further Reading
BSE NEWS: Variant More Virulent than Classical Form
BLUETONGUE: Dutch Opt for Voluntary Vaccination
Boosting the Bottom Beef Line
Keeping Afloat in the Turbulent UK Beef Market
Dairy Demand Drops in Heat of Economy
Bid to Cut Emissions as Consumption Increases
Hong Kong Concerned with Beef Tampering
New Animal Health Lab Likely to be in Kansas
Violence in Pakistan Disrupts Milk Trade
